Erasca Stock

erasca.comBioTechFounded: 2018Funding to Date: $64MM

Erasca is a biotechnology company committed to solving oncology’s hardest problems.

Register for Details

For more details on financing and valuation for Erasca, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Gary Yeung
Chief Business Officer
Jonathan Lim MD
Founder and Executive Chairman

Board Members

Alexander Casdin
James Bristol Ph.D
Jonathan Lim MD
Pratik Multani MD

Other companies like Erasca in the BioTech sector

Sector
Last Round Est. Valuation
$143.8MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$138.75MM
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$289.42MM
Sector
Last Round Est. Valuation
$1.08B

News

Erasca will use the funding to drive corporate development efforts and further advance the company’s in-house drug discovery pipeline.
San Diego-based cancer treatment startup Erasca raised $200 million in a new round of funding, the company announced Monday.
Erasca, a San Diego, CA-based develper of oncology programs, completed a $200m Series B financing round co-led by Arch Venture Partners and Cormorant Asset Management